Healthcare

Thursday 29 May 2025 - An overview of white biotechnology and its growing market opportunities; Exploration of major regulatory trends, including their impact on bioplastics such as PLA and PHAs; Insights into emerging technologies, such as AI-driven enzyme and protein engineering; Developments in fermentation and reactor systems aimed at improving biomanufacturing efficiency; Examination of persistent challenges, particularly around downstream processing (DSP); A forward-looking perspective on biomanufactured chemicals. IDTechEx's conclusions and strategic perspectives on the role of white biotechnology in a sustainable future

White biotechnology, which uses engineered microbes to produce chemicals, materials, and fuels, is emerging as a key driver of the sustainable bioeconomy by offering lower-carbon alternatives to fossil-based manufacturing. Advances in genetic engineering, synthetic biology, and regulatory support are expanding their applications across industries, though commercial success depends on factors like scalability, process efficiency, and market acceptance of green premiums.

The medical sector is one of the largest spaces where 3D printing operates, with opportunities for implant customization, educational models, and drug manufacturing.

People with diabetes have long been at the forefront of adopting digital health technologies, using digital platforms to seek out support, information about their condition, and to better understand the data that comes from managing it. The growing integration of wearable sensors and device data into digital health apps provides people with diabetes support right at their fingertips.

Worldwide, 830 million people were reported to have diabetes in 2022. Diabetes management is, therefore, a vital technology sector due to the complications that can occur as a result of the condition, the importance of which is highlighted by the market's multi-billion-dollar value.

Diabetes is a chronic condition that affects millions of people worldwide. The condition requires close and careful management to avoid severe health consequences. Today, people with diabetes have access to sophisticated automated insulin dosing (AID) systems that help in many aspects of diabetes management. IDTechEx forecasts that with further developments in AID systems, the diabetes management market can reach US$44 billion by 2035.

The rise of Continuous Glucose Monitoring (CGM) has reshaped the diabetes management technology market. With the market projected to reach US$44 billion by 2035, CGM technology is transforming diabetes care by replacing painful fingerstick tests and providing real-time glucose insights.

A free collection of insights from our industry experts, sharing some of the key technology innovation trends shaping the next decade.

Thursday 30 January 2025 - Introduction to diabetes and the role of medical devices in managing blood glucose; Roadmap of glucose sensing technologies including recent developments in continuous glucose monitoring; Discussion of insulin delivery options, including key challenges of each; Future of diabetes management technologies

With over 800 million people with diabetes in the world today, the market for diabetes management is substantial. IDTechEx forecasts the market for diabetes management technologies to exceed US$44 billion by 2035, with continuous glucose monitors (CGM) and insulin pump markets driving growth in the next ten years.